logo

Astrazeneca Plc (AZN.L)



Trade AZN.L now with
  Date
  Headline
9/23/2022 2:04:22 AM AstraZeneca: Ultomiris Approved In Europe For Adults With Generalised Myasthenia Gravis
9/22/2022 2:05:43 AM AstraZeneca Says Lynparza Approved In China For Ovarian Cancer
9/21/2022 2:02:05 AM AstraZeneca Says Tezspire Approved In EU For The Treatment Of Severe Asthma
9/20/2022 2:08:42 AM AstraZeneca Says Evusheld Approved In EU For COVID-19 Treatment
9/16/2022 3:21:28 AM AstraZeneca PLC Says Danicopan Phase III Trial Meets Primary Endpoint
9/16/2022 2:07:59 AM AstraZeneca Says Evusheld Recommended For Marketing Authorisation In EU For The Treatment Of COVID-19
9/16/2022 2:05:25 AM AstraZeneca PLC Says Beyfortus Recommended For Approval In The EU By CHMP
9/9/2022 8:04:52 AM AstraZeneca : LYNPARZA Combination Shows Meaningful Survival Benefit In Ovarian Cancer Across Phase III Trials
9/7/2022 2:33:47 AM Ionis Presents Positive Results From Phase 3 NEURO-TTRansform Study On Amyloidosis